Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Abbott/TAP discover safer LHRH antagonists

April 3, 1998

Stehlin Foundation describes new camptothecins with improved stability

April 3, 1998

New prenyl transferase inhibitors in development at BMS

April 3, 1998

Neovastat efficacy reported at AACR

April 3, 1998

Genetix cancer gene therapy approach gives promising results in preliminary studies

April 3, 1998

New inhibitors of cell adhesion in development at Kao

April 3, 1998

Liposomal telomerase antisense oligonucleotide effective alone and in combination

April 2, 1998

Protein farnesyltransferase inhibitor advanced to clinical trials by Schering-Plough

April 2, 1998

Dramatic anticancer activity observed with FGN-1 in animal models

April 2, 1998

MGI Pharma presents MGI-114 data at AACR

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...